Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study Group.
Steinherz PG, Gaynon P, Miller DR, Reaman G, Bleyer A, Finklestein J, Evans RG, Meyers P, Steinherz LJ, Sather H, et al. Steinherz PG, et al. Among authors: gaynon p. J Clin Oncol. 1986 May;4(5):744-52. doi: 10.1200/JCO.1986.4.5.744. J Clin Oncol. 1986. PMID: 3517244 Clinical Trial.
Modified BFM therapy for children with previously untreated acute lymphoblastic leukemia and unfavorable prognostic features. Report of Children's Cancer Study Group Study CCG-193P.
Gaynon PS, Bleyer WA, Steinherz PG, Finklestein JZ, Littman PS, Miller DR, Reaman GH, Sather HN, Hammond GD. Gaynon PS, et al. Am J Pediatr Hematol Oncol. 1988 Spring;10(1):42-50. doi: 10.1097/00043426-198821000-00009. Am J Pediatr Hematol Oncol. 1988. PMID: 3056061 Clinical Trial.
Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer Group.
Nachman J, Sather HN, Gaynon PS, Lukens JN, Wolff L, Trigg ME. Nachman J, et al. Among authors: gaynon ps. J Clin Oncol. 1997 Jun;15(6):2222-30. doi: 10.1200/JCO.1997.15.6.2222. J Clin Oncol. 1997. PMID: 9196134 Clinical Trial.
Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group.
Reaman GH, Sposto R, Sensel MG, Lange BJ, Feusner JH, Heerema NA, Leonard M, Holmes EJ, Sather HN, Pendergrass TW, Johnstone HS, O'Brien RT, Steinherz PG, Zeltzer PM, Gaynon PS, Trigg ME, Uckun FM. Reaman GH, et al. Among authors: gaynon ps. J Clin Oncol. 1999 Feb;17(2):445-55. doi: 10.1200/JCO.1999.17.2.445. J Clin Oncol. 1999. PMID: 10080584 Clinical Trial.
220 results